CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating expenses:
Research and development	$ 24,988	$ 24,172
General and administrative	5,888	12,392
Total operating expenses	30,876	36,564
Loss from operations	(30,876)	(36,564)
Other income, net:
Interest income	2,838	4,376
Other income, net	206	205
Total other income, net	3,044	4,581
Net loss	(27,832)	(31,983)
Other comprehensive loss:
Net unrealized loss on investments	(537)	(22)
Comprehensive loss	$ (28,369)	$ (32,005)
Net loss per share, basic	$ (0.37)	$ (0.43)
Net loss per share, diluted	$ (0.37)	$ (0.43)
Weighted average shares used to compute net loss per share, basic	74,257,973	73,916,477
Weighted average shares used to compute net loss per share, diluted	74,257,973	73,916,477